EMA Guideline on strategies to identify and mitigate risks for first-in-human and early clinical trials with investigational medicinal products

https://www.ema.europa.eu/en/documents/scientific-guideline/guideline-strategies-identify-mitigate-risks-first-human-early-clinical-trials-investigational_en.pdf

Leave a Comment

Your email address will not be published. Required fields are marked *

Scroll to Top